Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis

Practical Laboratory Medicine(2024)10.1016/j.plabm.2024.e00420Source: DataRank Database

A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis is a research paper published in Practical Laboratory Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.98)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Dipanwita Banerjee ORCID,Camille L. Novis ORCID,Kevin D. Deane ORCID,Marie L. Feser ORCID,Vijayalakshmi Nandakumar

Live enrichment

PubMed:39161944 PMC:PMC11332063 OpenAlex:https://openalex.org/W4400865052

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: P30 AR079369

National Institutes of Health

Grant: 5P30AR079369-02

Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis

National Institutes of Health

ARUP Laboratories

Arup Institute for Clinical and Experimental Pathology

University of Colorado Anschutz Medical Campus

FWCI

0.98

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.plabm.2024.e00420

GOLDhttps://doi.org/10.1016/j.plabm.2024.e00420

publisherhttps://doi.org/10.1016/j.plabm.2024.e00420

publisherhttps://api.elsevier.com/content/article/PII:S2352551724000660?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352551724000660?httpAccept=text/plain

Fields of Study

Rheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies ResearchMedicine0303 health sciences03 medical and health sciences

Keywords

AutoantibodyRheumatoid arthritisMedicineAntibodyImmunologyDiagnostic PerformanceCyclic Citrullinated Peptide AntibodiesRegistered Report Stage IIMedicine (General)ChemistryR5-920QD1-999

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being